Analysts/Institutional Investor Meet/Con. Call Updates

Alembic Pharmaceuticals management has scheduled one-to-one meetings with various investors and analysts, including Dolat Capital, Equirus Securities, ICICI Securities, Ashmore, and HSBC, on September 1 and 2. These engagements will not involve sharing any unpublished price sensitive information.